InspireMD Inc. (NSPR)
NASDAQ: NSPR
· Real-Time Price · USD
2.59
0.05 (1.97%)
At close: May 01, 2025, 3:59 PM
2.48
-4.25%
After-hours: May 01, 2025, 04:53 PM EDT
InspireMD Revenue Breakdown
| Period Ending | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 |
|---|---|---|---|
| Cguard Revenue | 277K | 355K | 243K |
| Cguard Revenue Growth | -21.97% | +46.09% | n/a |
| MGuard Revenue | 192K | 185K | 320K |
| MGuard Revenue Growth | +3.78% | -42.19% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2015 | Dec 31, 2014 |
|---|---|---|
| Belarus Revenue | 226K | 285K |
| Belarus Revenue Growth | -20.70% | n/a |
| Brazil Revenue | 238K | 286K |
| Brazil Revenue Growth | -16.78% | n/a |
| Germany Revenue | 519K | 792K |
| Germany Revenue Growth | -34.47% | n/a |
| Italy Revenue | 415K | n/a |
| Italy Revenue Growth | n/a | n/a |
| Middle East Revenue | 94K | n/a |
| Middle East Revenue Growth | n/a | n/a |
| Other Revenue | 818K | n/a |
| Other Revenue Growth | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.96M | 5.19M | 5.08M | 4.28M | 3.97M | 3.81M | 2.91M | 3.12M | 2.92M | 3.06M | 2.93M | 2.69M | 2.63M | 2.41M | 2.58M | 2.61M | 1.95M | 1.88M | 1.79M | 2.24M | 1.68M | 1.76M | 1.93M | 1.8M | 1.76M | 1.52M | 1.99M | 1.43M | 1.95M | 2.04M | 2.13M | 1.69M | 1.51M | 1.56M | 1.98M | 1.7M | 2.3M | 2.58M | 2.99M |
| Selling, General, and Administrative Revenue Growth | -4.41% | +2.15% | +18.77% | +7.84% | +4.04% | +30.99% | -6.73% | +7.07% | -4.61% | +4.37% | +8.81% | +2.40% | +8.96% | -6.55% | -1.04% | +33.95% | +3.45% | +4.96% | -20.06% | +33.27% | -4.38% | -8.90% | +7.57% | +1.99% | +15.86% | -23.77% | +39.93% | -26.92% | -4.32% | -4.23% | +25.69% | +11.97% | -3.14% | -20.96% | +16.52% | -26.34% | -10.88% | -13.56% | n/a |
| Research and Development Revenue | 3.92M | 3.4M | 2.63M | 2.04M | 2.11M | 1.99M | 1.84M | 2.01M | 2.06M | 2.06M | 1.68M | 1.53M | 1.5M | 1.29M | 839K | 720K | 546K | 444K | 523K | 522K | 442K | 865K | 1.13M | 637K | 416K | 230K | 252K | 235K | 288K | 403K | 350K | 345K | 289K | 301K | 478K | 762K | 781K | 747K | 1.35M |
| Research and Development Revenue Growth | +15.11% | +29.56% | +28.99% | -3.55% | +5.87% | +8.14% | -8.45% | -2.33% | +0.24% | +22.38% | +9.52% | +2.61% | +15.89% | +53.75% | +16.53% | +31.87% | +22.97% | -15.11% | +0.19% | +18.10% | -48.90% | -23.11% | +76.61% | +53.12% | +80.87% | -8.73% | +7.23% | -18.40% | -28.54% | +15.14% | +1.45% | +19.38% | -3.99% | -37.03% | -37.27% | -2.43% | +4.55% | -44.75% | n/a |
| Sales and Marketing Revenue | 1.47M | 1.45M | 1.24M | 1.31M | 876K | 892K | 788K | 1.09M | 845K | 986K | 746K | 761K | 802K | 636K | 708K | 617K | 485K | 377K | 624K | 605K | 537K | 620K | 634K | 564K | 605K | 580K | 492K | 522K | 671K | 632K | 532K | 382K | 329K | 401K | 386K | 578K | 588K | 995K | 1.02M |
| Sales and Marketing Revenue Growth | +1.87% | +16.81% | -5.50% | +49.43% | -1.79% | +13.20% | -27.51% | +28.64% | -14.30% | +32.17% | -1.97% | -5.11% | +26.10% | -10.17% | +14.75% | +27.22% | +28.65% | -39.58% | +3.14% | +12.66% | -13.39% | -2.21% | +12.41% | -6.78% | +4.31% | +17.89% | -5.75% | -22.21% | +6.17% | +18.80% | +39.27% | +16.11% | -17.96% | +3.89% | -33.22% | -1.70% | -40.90% | -2.16% | n/a |